We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.52%
2 Healthcare 9.35%
3 Financials 9.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRX icon
2801
Xerox
XRX
$412M
$571K ﹤0.01%
39,084
-3,433
-8% -$51.8K
AAXJ icon
2802
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
$570K ﹤0.01%
8,802
-243
-3% -$15K
XSW icon
2803
State Street SPDR S&P Software & Services ETF
XSW
$515M
$570K ﹤0.01%
5,243
+236
+5% +$25.9K
MYOV
2804
DELISTED
Myovant Sciences Ltd.
MYOV
$570K ﹤0.01%
+21,134
New +$556K
MFM
2805
Aberdeen Municipal Income Fund
MFM
$223M
$568K ﹤0.01%
109,580
+49,263
+82% +$245K
MHD icon
2806
BlackRock MuniHoldings Fund
MHD
$604M
$567K ﹤0.01%
46,739
+3,063
+7% +$35.2K
COIN icon
2807
Coinbase
COIN
$40.6B
$567K ﹤0.01%
16,032
-16,225
-50% -$855K
OSIS icon
2808
OSI Systems
OSIS
$3.82B
$567K ﹤0.01%
7,128
+2,201
+45% +$179K
MKC.V icon
2809
McCormick & Company Voting
MKC.V
$14.2B
$567K ﹤0.01%
6,895
CVSA
2810
Covista Inc
CVSA
$4.36B
$566K ﹤0.01%
15,934
-64
-0.4% -$2.5K
SJI
2811
DELISTED
South Jersey Industries, Inc.
SJI
$565K ﹤0.01%
15,916
-4,193
-21% -$145K
EXC icon
2812
CALL
Exelon
EXC
$46.6B
$565K ﹤0.01%
19,900
MXL icon
2813
MaxLinear
MXL
$6.95B
$564K ﹤0.01%
16,624
-11,333
-41% -$384K
GLNG icon
2814
Golar LNG
GLNG
$5.21B
$564K ﹤0.01%
24,753
-38,803
-61% -$971K
AGNT
2815
AGNT Inc
AGNT
$752M
$563K ﹤0.01%
50,855
+17,555
+53% +$213K
BCV
2816
Bancroft Fund
BCV
$144M
$563K ﹤0.01%
34,397
+798
+2% +$13.7K
WFRD icon
2817
Weatherford International
WFRD
$6.6B
$563K ﹤0.01%
+11,056
New +$456K
NUSC icon
2818
Nuveen ESG Small-Cap ETF
NUSC
$1.35B
$563K ﹤0.01%
16,461
-200
-1% -$6.98K
DDD icon
2819
3D Systems Corp
DDD
$601M
$562K ﹤0.01%
76,010
-646
-0.8% -$5.67K
NRIX icon
2820
Nurix Therapeutics
NRIX
$2.76B
$560K ﹤0.01%
51,031
-48
-0.1% -$579
XNCR icon
2821
Xencor
XNCR
$1.71B
$559K ﹤0.01%
+21,464
New +$600K
NMAI icon
2822
Nuveen Multi-Asset Income Fund
NMAI
$497M
$557K ﹤0.01%
48,477
-26,403
-35% -$307K
INSM icon
2823
Insmed
INSM
$28.9B
$555K ﹤0.01%
27,791
+6,131
+28% +$119K
OUT icon
2824
Outfront Media
OUT
$5.29B
$554K ﹤0.01%
33,935
-2,583
-7% -$43.6K
EMQQ icon
2825
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$268M
$553K ﹤0.01%
+18,614
New +$506K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.